Aldehyde dehydrogenase (ALDH) is cancer prognostic marker and plays as marker of cancer stem cells (CSCs).
ALDH takes part in retinoic acid-mediated signalling, reducing active oxygen species and resisting drug toxicity.
ALDH is regulated by RA, Notch, Wnt or TGF-β pathways in CSCs.